Advertisement

Molecular Diagnosis of Hereditary Thrombotic Disorders

  • James G. Donnelly
Part of the Methods in Molecular Medicine™ book series (MIMM, volume 49)

Abstract

Deep vein thrombosis (DVT) can be the result of coagulation pathway defects at the molecular level or damage to the vascular endothelium. Some of the acquired causes of DVT include malignancy, trauma, prolonged immobilization, and pregnancy (1). Thrombophilia can be owing in part to both acquired and inherited defects. The relative risk for thrombosis is increased by estrogen replacement therapy (2) and homocysteinemia (3). Homocysteine metabolism is influenced by the use of alcohol, anticonvulsant drugs, cyclosporine, methotrexate, inadequate dietary vitamin B12, folate and pyridoxine intake, organ transplantation, and reduced creatinine clearance (4, 5, 6, 7, 8). Similar to venous thrombosis, homocysteinemia has genetic factors that influence susceptibility (9, 10, 11).

Keywords

Deep Vein Thrombosis Polymerase Chain Reaction Assay Factor Versus MTHFR C677T Prothrombin G20210A 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Appleby, R. D. and Olds, R. J. (1997) The inherited basis of venous thrombosis. Pathology 29, 341–347.PubMedCrossRefGoogle Scholar
  2. 2.
    Helmerhorst, F. M., Bloemenkamp, K. W., Rosendaal, F. R., and Vandenbroucke, J. P. (1997) Oral contraceptives and thrombotic disease: risk of venous throm-boembolism. Thromb. Haemost. 78, 327–333.PubMedGoogle Scholar
  3. 3.
    D’′’′’′’Angelo, A., Mazzola, G., Crippa, L., Fermo, I., and Vigano, D. S. (1997) Hyperhomocysteinemia and venous thromboembolic disease. Haematologica 82, 211–219.Google Scholar
  4. 4.
    Cravo, M. L., Gloria, L. M., Selhub, J., et al. (1996) Hyperhomocysteinemia in chronic alcoholism: correlation with folate, vitamin B-12, and vitamin B-6 status. Am. J. Clin. Nutr. 63, 220–224.PubMedGoogle Scholar
  5. 5.
    Lucock, M. D., Wild, J., Schorah, C. J., Levene, M. I., and Hartley, R. (1994) The methylfolate axis in neural tube defects: in vitro characterisation and clinical investigation. Biochem. Med. Metab. Biol. 52, 101–114.PubMedCrossRefGoogle Scholar
  6. 6.
    Arnadottir, M., Hultberg, B., Vladov, V., Nilsson, E. P., and Thysell, H. (1996) Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients. Transplantation 61, 509–512.PubMedCrossRefGoogle Scholar
  7. 7.
    Keuzenkamp, J. C., De, A. R., Blom, H. J., Bokkerink, J. P., Trijbels, J. M. (1996) Effects on transmethylation by high-dose 6-mercaptopurine and methotrexate infusions during consolidation treatment of acute lymphoblastic leukemia. Biochem. Pharmacol. 51, 1165–1171.CrossRefGoogle Scholar
  8. 8.
    Brattstrom, L., Lindgren, A., Israelsson, B., Andersson, A., and Hultberg, B. (1994) Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J. Intern. Med. 236, 633–641.PubMedCrossRefGoogle Scholar
  9. 9.
    Bertina, M. R., Koeleman, B. P. C., Koster, T., et al. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369, 64–67.PubMedCrossRefGoogle Scholar
  10. 10.
    Frosst, P., Blom, H. J., Milos, R., et al. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10, 111–113.PubMedCrossRefGoogle Scholar
  11. 11.
    Poort, S. R., Rosendaal, F. R., Reitsma, P. H., and Bertina, R. M. (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88, 3698–3703.Google Scholar
  12. 12.
    Koster, T., Rosendaal, F. R., de Ronde, H., Briet, E., Vandenbroucke, J. P., and Bertina, R. M. (1993) Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 342, 1503–1506.PubMedCrossRefGoogle Scholar
  13. 13.
    Svensson, P. J. and Dalback, B. (1994) Resistance to activated protein C as a basis for venous thrombosis. N. Engl. J. Med. 330, 517–522.PubMedCrossRefGoogle Scholar
  14. 14.
    Griffin, J. H., Evatt, B., Wideman, C., and Fernandez, J. A. (1993) Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 82, 1908–1993.Google Scholar
  15. 15.
    Jacques, P. F., Bostom, A. G., Williams, R. R., et al. (1996) Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93, 7–9.PubMedGoogle Scholar
  16. 16.
    den Heiger, M., Blom, H. J., Gerrits, W. B., et al. (1995) Is hyperhomo-cysteinaemia a risk factor for recurrent venous thrombosis? Lancet 345, 882–885.CrossRefGoogle Scholar
  17. 17.
    Ridker, P. M., Hennekens, C. H., Lindpaintner, K., Stampfer, M. J., Eisenberg, P. R., and Miletich, J. P. (1995) Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N. Engl. J. Med. 332, 912–917.PubMedCrossRefGoogle Scholar
  18. 18.
    Liebman, H. A., Sutherland, D., Bacon, R., and McGehee, W. (1996) Evaluation of a tissue factor dependent factor V assay to detect factor V Leiden: demonstration of high sensitivity and specificity to a generally applicable assay for activated protein C resistance. Br. J. Haematol. 95, 550–553.PubMedCrossRefGoogle Scholar
  19. 19.
    Donnelly, J. G. (1998) Homocysteine and plasma folate relationship in patients with venous thrombosis, end-stage renal disease or atherosclerosis. Clin. Chem. 44(Suppl. 6), A167,A168.Google Scholar
  20. 20.
    Bostom, A. G., Roubenoff, R., Dellaripa, P., et al. (1995)Validation of abbreviated oral methionine-loading test. Clin. Chem. 41, 948,949.Google Scholar
  21. 21.
    Wasserman, L. M., Edson, J. R., Key, N. S., Chibbar, R., and McGlennen, R. C. (1997) Detection of the factor V Leiden mutation: development of a testing algorithm combining a coagulation assay and molecular diagnosis. Am. J. Clin. Pathol. 108, 427–433.PubMedGoogle Scholar
  22. 22.
    Adcock, D. M., Fink, L., and Marlar, R. A. (1997) A laboratory approach to the evaluation of hereditary hypercoagulability. Am. J. Clin. Pathol. 108, 434–449.PubMedGoogle Scholar

Copyright information

© Humana Press Inc. 2001

Authors and Affiliations

  • James G. Donnelly
    • 1
  1. 1.Department of Laboratory MedicineOttawa Hospital Civic CampusOttawaCanada

Personalised recommendations